Gilead Sciences CFO Andrew Dickinson Sells $435K in Common Stock Under 10b5-1 Plan
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Sale Alert: GILEAD SCIENCES, INC. ($GILD) • Insider: Dickinson Andrew D (Chief Financial Officer) • Transaction: Sold 3,000 shares of Common Stock at $145.29 per share ($435,870.00 total) • Post-Transaction Holdings: 164,096 shares (Direct) • Plan: Rule 10b5-1 trading plan adopted August 29, 2024 • Date: 2026-09-15
Comprehensive Analysis
Insider Transaction Overview
On September 15, 2026, Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, Inc. ($GILD), executed a sale of 3,000 shares of common stock at a price of $145.29 per share, generating total proceeds of $435,870.00.
Key Highlights
- Transaction Code: S (Open-market or private sale)
- Pre-Determined Plan: The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on August 29, 2024.
- Position Impact: Following the transaction, Dickinson directly owns 164,096 shares of Gilead Sciences common stock. The sold shares represent approximately 1.8% of his direct holdings.
- Market Significance: Low. The trade was pre-scheduled under a 10b5-1 plan and represents a minor reduction in total equity ownership.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.